EMJ | Elevating the quality of healthcare globally

This site is intended for healthcare professionals

Continue

Latest News

All News
Cardiology
29 Aug 2026

Imaging Reveals Widespread Silent Atherosclerosis Burden: ESC 2026

Findings from a large imaging study presented during ESC Congress 2026 suggested silent atherosclerosis present in more than half of adults without known cardiovascular disease.
Diabetes
29 Aug 2026

GLP1 Medication Linked to Lowered Risk of TB in Type 2 Diabetes

GLP-1 receptor agonists were linked to a lower risk of tuberculosis in people with type 2 diabetes.
Cardiology
29 Aug 2026

CKD Screening Recommended in Heart Disease: ESC 2026

New ESC guidelines call for routine CKD screening in patients with CVD, aiming to improve early diagnosis, optimise treatment, and reduce cardiovascular and kidney complications.
Gastroenterology
29 Aug 2026

Leukocyte Telomere Length Shows Limited Value in Pancreatic Cancer

Leukocyte telomere length showed limited diagnostic and prognostic value in pancreatic ductal adenocarcinoma, while exploratory microbiome data found no significant group differences.
Urine Tumour DNA Predicts BCG Recurrence - EMJ
Urology
29 Aug 2026

Urine Tumour DNA Predicts Bladder Cancer Recurrence

Urine tumour DNA testing identified patients at increased recurrence risk following BCG treatment and detected some recurrences months before clinical diagnosis.
Neurology
29 Aug 2026

Growth Factor Receptors Signal Schizophrenia Disease Stage

Researchers identified lower nGFR levels in early psychosis and elevated eGFR and ITGB1 across schizophrenia spectrum disorders.
Allergy & Immunology
29 Aug 2026

Placental Epigenetic Changes Link to Persistent Food Allergy

Placental DNA methylation changes, reduced IL-10, and elevated Th2 cytokines were associated with an early persistent food allergy trajectory.
Reproductive Health
29 Aug 2026

Cell-Free DNA May Predict Pregnancy Complications

First-trimester cell-free DNA patterns could help identify patients at increased risk of adverse pregnancy outcomes.
Cardiology
28 Aug 2026

Polygenic Risk Score Improves CAD Risk Assessment: ESC 2026

A real-world study found that polygenic risk score reclassified coronary artery disease risk in 42.6% of moderate risk patients and was associated with improvements in cardiovascular risk factors.

Latest Articles

Interactive Content

Respiratory
28 Aug 2026

Chronic Cough Mechanism and Treatment​

Chronic cough, defined as a cough that lasts ≥8 weeks, is highly prevalent in patients with IPF. It is reported in approximately 85% of…
Respiratory
17 Jul 2026

Extracorporeal CO₂ Removal in Clinical Practice

This interactive case study allows clinicians to examine a patient with COPD presenting with an acute exacerbation…
General Healthcare
10 Jul 2026

The European Clinician's Guide to AI Tools

Explore approved AI tools for EU and UK clinicians in 2026, with evidence, CE/MHRA status, and practical guidance across specialties.
Urology
8 Jul 2026

Cardiovascular Risk and ADT in Prostate Cancer

This infographic is sponsored by Accord Healthcare and it’s intended for Health Care Professionals only
All Interactive Content

Latest Infographics

All Infographics
Respiratory
28 Aug 2026

Chronic Cough Mechanism and Treatment​

Chronic cough, defined as a cough that lasts ≥8 weeks, is highly prevalent in patients with IPF. It is reported in approximately 85% of…
Flagship Journal
11 Aug 2026

When Inflammation Becomes Visible: Understanding its Burden

AD is a common, chronic, immune-mediated, inflammatory skin disease. Hand involvement is present in up to 56% of patients with moderate…
Microbiology & Infectious Diseases
29 Jul 2026

Balancing speed and stewardship in AMR

In the UK, Fetcroja® (Cefiderocol) is indicated for the treatment of infections due to aerobic Gram-negative organisms in adults with…
Microbiology & Infectious Diseases
28 Jul 2026

Overcoming Cefiderocol AST Challenges in MDR-GN Infections: A Stepwise Approach

Inappropriate and delayed appropriate antibiotic therapy has a major impact on survival.1,2Antimicrobial susceptibility results obtained as…

Latest Podcasts

All Podcasts
Radiology
28 Aug 2026

Innovation, Research, and Inclusion in Interventional Radiology

In this series, host Saranya Ravindran speaks with Lakshmi Ratnam about the evolving landscape of interventional radiology and how…
Hematology
26 Aug 2026

Hema Now: What’s Next in Leukaemia Treatment?

Daniel DeAngelo, Chief of the Division of Leukemia, Dana-Farber Cancer Institute; and Professor of Medicine, Harvard Medical School…
General Healthcare
24 Aug 2026

Innovation, Research, and Inclusion in Healthcare Equity

In this series, host Catherine Glass speaks with Carl Streed Jr about advancing equity and inclusion for sexual…
Oncology
18 Aug 2026

Onc Now: Microbes, AI, and the Future of Precision Oncology

In this episode of Onc Now, Miguel Reis Ferreira explores the evolving relationship between the microbiome and cancer, from…

Latest Videos & Webinars

All Videos & Webinars
Gastroenterology
27 Aug 2026

Rome V and Functional Dyspepsia

Watch expert-led discussions on the latest Rome V guidance for functional dyspepsia, from diagnosis and biology to evidence-based…
Reproductive Health
24 Aug 2026

Our Latest Reproductive Health Journal

EMJ’s latest Reproductive Health journal is now live! Inside, explore highlights and insights from ESHRE 2026. Discover insights from…
Hematology
21 Aug 2026

EHA 2026: Claire Harrison on MPNs, Myelofibrosis, and JAK Inhibitors

EMJ spoke with Claire Harrison about receiving the EHA 2026 Lifetime Achievement Award, her pioneering work in MPNs.
We’ve noticed you’re accessing
from North/South America.